New Physicians to be added as follows:
Karen Seiter, M.D. completed her residency at the Albert Einstein College of Medicine, Bronx, New York and continued on to her fellowship at Memorial Sloan Kettering Cancer Center, New York, New York. She is board certified in Internal Medicine, Hematology and Medical Oncology. Dr. Seiter is Professor of Medicine at New York Medical College in Valhalla, New York and is affiliated with Westchester Medical Center, Valhalla, New York. Her academic responsibilities at those institutions include Director of the Adult Leukemia Service, Chair of the Oncology Committee for Protection of Human Subjects (Institutional Review Board), Associate Director of the Hematology/Medical Oncology Fellowship Program, and Member of the Oncology Leadership Council. She has also been involved in several safety initiatives as Chair of the Medication Use and Safety Committee at Westchester Medical Center. Dr. Seiter is a principal investigator on many clinical trials of new agents in acute leukemia, myelodysplastic syndromes, and other hematologic disorders. She has published more than 100 articles on the results of these trials.
Outside of hematology, Dr. Seiter is a strong advocate for aerospace medicine and space exploration. She is on the Board of Directors of the Cradle of Aviation Museum, Garden City, New York, and is a member of several related societies.
Dr Gino Bottino has been in practice at Northern Westchester Hospital for over 31 years after having left the National Cancer Institute as a researcher.
Dr Bottino is an active and caring member of his community. He frequently gives talks to community associations and at events. As a board member of the American Cancer Society he attends events and has been interviewed on TV.
He has provided a leadership role at Northern Westchester Hospital Center by being the chairman of both the Cancer Program, and Hematology, and Blood Banking Services. He started the Oncology program at Northern Westchester hospital 15 years ago when he moved his practice into the hospital itself.
He is the chairman of the Ethics Committee for the Westchester County Medical Society of which he is on the board of Directors; and he is active in many other national and local Medical organizations. As a member of the NY State medical Society, he is on the NY State Cancer committee and the NY State Ethic committee.
Dr. Bottino has been teaching at NY Medical College for 25 years, and before that at NYU. Last year Dr Bottino received the Chancellor’s Award for Excellence in teaching at NY Medical College
Well known for his high level of caring for his patients; in 2012 he received the Bishop’s Award for Compassionate Care.
He is a member of the National Medical Honor Society Alfa Omega Alfa and graduated top in his class in medical school being given the NY State Surgical Society award for graduating first in the state for surgery.
Dr Bottino has published many medical papers and continues to do research in both Hematology and Oncology carrying on in research since his days at the National Cancer Institute.
He is also an avid sailor since the age of 10 and has won many inshore and offshore races. Having a series of boats named Raven, which are well known threw out the USA, he continues to sail as a registered US sailing Athlete.
Carmelo A. Puccio, MD
Carmelo Puccio, MD is an attending physician at Westchester Medical Center, Hudson Valley Hospital
Center, St. John ‘s Riverside and Phelps Memorial Hospital. Born in Buenos Aires, Argentina, Dr. Puccio came to the U.S. as a child, graduated from Fordham University and received his medical degree from
the IJniversidad Autonoma de Guadalajara in Mexico (valedictorian). His Internal Medicine residency was at Maimoides Medical Center and Fellowship in Oncology-Hemato’ogy was through New York Medical College. Dr, Puccio is Board Certified in Medical Oncology and specializing in solid tumor management. Dr. Puccio cares for patients with lun% breast, gynecologic, head and neck cancers with unsurpassed -expertiSe. He played a key rote as member of the New York Medical College team that spearheaded research on interleukin-2, oxaliplatin and fludarabine which today are standard therapies for a variety oi cancers. He has a special interest in developing approaches to improve quality of life for patients undergoing cancer treatment. As Assistant Professor of Medicine, Dr. Puccio mentors medical students, interns and residents. He is a frequent lecturer and has published numerous papers on a variety of cancer-retated topics. Dr. Puccio cares for a highly international group of patients and is fluent in English, Spanish and Italian.
Dr. Sheetal H. Shrimanker graduated from the University of Pennsylvania for her undergraduate studies and from New York Medical College for medical school. She completed her Internal Medicine Residency in 2008 and Hematology and Oncology Fellowship training in 2011 at Robert Wood Johnson University Hospital/UMDNJ and the Cancer Institute of New Jersey. She is board certified in Internal Medicine, Hematology, and Medical Oncology. She is affiliated with Phelps Memorial Hospital Center, Westchester Medical Center, St. Johns Riverside Hospital, and Hudson Valley Hospital Center. Her focus of interest is in lung cancer and lymphomas.
Tauseef Ahmed M.D., F.A.C.P.
Dr. Tauseef Ahmed is Chief of Oncology at Westchester Medical Center.He is a widely recognized expert in the subspecialty fields of Oncology and Hematology who has practiced in the Hudson Valley Region for over 25 years. After basic training at King Edward Medical College in Pakistan and medical residency training at Sinai Hospital of Detroit, he completed fellowship training in medical oncology with a specialty in genitourinary cancers at Memorial Sloan Kettering Cancer Center and at the Fred Hutchison Cancer Research Center in Seattle which prepared him for his role as Director of Stem Cell Transplantation. His appointments include Professor of Medicine for New York Medical College. He has extensive experience in the field with special interests in the management of Hodgkin’s and non-Hodgkin’s lymphomas, stem cell transplantation, genitourinary and breast cancers. As a recognized clinical investigator, Dr. Ahmed played a key role in pioneering the establishment of many techniques and approaches that are today considered standards of care including development of the M-VAC regimen for bladder cancer, peripheral stem cell technology applications, cryopreservation techniques, tandem and non-myeloablative transplant conditioning regimens for hematologic malignancies and selected solid tumors. Dr. Ahmed has lectured extensively in both national and international settings, been awarded numerous research grants and has published over 200 papers, book chapters and abstracts on a variety of cancer-related topics. Dr. Ahmed is fluent in English, Urdu, Punjabi and Hindi.